logo
Share SHARE
FONT-SIZE Plus   Neg

Court Rules In Favor Of Boston Scientific In Johnson & Johnson Litigation

Medical device maker Boston Scientific Corp. (BSX) announced that the U.S. District Court for the District of New Jersey has found all the asserted patents in a suit brought by Healthcare giant Johnson & Johnson (JNJ) to be invalid and entered judgment in favor of Boston Scientific.

Under the 2008 patent infringement suit, Johnson & Johnson alleged that Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System infringed two patents, U.S. Patent Nos. 5,516,781 and 5,563,146. The patents relate to the use of a drug on a drug-eluting stent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google plans to de-rank articles from Russian state-owned media sites, Russia Today and Sputnik, following allegations about Kremlin meddling in U.S. electoral processes. Eric Schmidt, the executive chairman of Google's parent company Alphabet, said Google would begin to reduce the presence of Russia Today and Sputnik. Federal Communications Commission Chairman Ajit Pai has announced plans to repeal the net neutrality rules implemented under President Barack Obama. Pai, who was appointed by President Donald Trump, said he circulated his draft order to his fellow FCC commissioners Tuesday morning, with the order... Reflecting expectations the House Republican tax reform bill would provide a relatively modest boost to economic growth, a new analysis by the Tax Policy Center found that the legislation would add about $1.3 trillion to the national debt over a decade.
comments powered by Disqus
Follow RTT